NANEMIAR project participated at the prestigious European Hematology Association (EHA) Annual Congress, held from June 12 to 15, 2025, in Milan, Italy. During the event, Dr. Laura Braud of the CNRS, presented the latest work from the NANEMIAR project with a scientific poster “A new Method for Analyzing Bone Marrow Cell Populations by Spectral Flow ...
News & Events
We had the honor of participating in the 3rd Congenital Anemia Patient Conference held at the Barceló Occidental Hotel in Murcia (Spain) last June 17th, 2025. This event brought together healthcare professionals, patients, and families to share scientific advancements, personal experiences, and future perspectives regarding these rare diseases. The...
In this fifth interview Dr. Eduardo Salido Fiérrez (Erythropathologist at Hospital Clínico Universitario Virgen de la Arrixaca (Murcian Health Service) - Murcian Institute of Biosanitary Research IMIB-FFIS (Spain) shares his clinical perspective and gives a glimpse into what a doctor's day is like when treating diseases such as congenital anemia. M...
Yesterday, May 8, we commemorate International Thalassemia Day, a day dedicated to raising awareness about this congenital and chronic hematological disease. Although it is not widely known, thalassemia affects the lives of thousands of people worldwide, who face ongoing challenges due to the complications of this condition. At #FFIS, #IMIB, and #M...
Last week, one of NANEMIAR’s partners - Jenny van Asbeck (Mercurna) - had the opportunity to speak at the 4th RNA Leaders Congress in Basel, Switzerland. It was great to share Mercurna’s latest advancements in targeted mRNA therapy development and to network with fellow researchers, industry leaders, and investors, all passionate about the future o...